Browsing Category
Pharma Industry News
4752 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Innovent begins IBI363 pivotal study in melanoma immunotherapy
Innovent Biologics, Inc. (HKEX: 01801), a global biopharmaceutical company specializing in innovative oncology therapies, has dosed the first…
CARsgen advances CAR T-cell therapies with breakthrough designation for satri-cel and first dose of KJ-C2219
CARsgen Therapeutics Holdings Limited has taken significant strides in the field of CAR T-cell therapy with two major…
hVIVO expands biopharma capabilities with Cryostore acquisition
hVIVO plc has completed the acquisition of Cryostore Limited, a specialist provider of temperature-controlled storage solutions, in a…
Longeveron 2024 revenue jumps 237%, eyes FDA approval for Lomecel-B
Longeveron Inc., a biotechnology company specializing in regenerative medicine, has reported significant financial progress alongside major advancements in…
4D Molecular Therapeutics strengthens cash position, eyes Phase 3 success for 4D-150
4D Molecular Therapeutics (4DMT) has announced its full-year 2024 financial results, highlighting key advancements in its late-stage clinical…
Recursion Pharmaceuticals’ stock plunges 7% after shock Q4 loss – What went wrong?
Recursion Pharmaceuticals, a clinical-stage biotechnology company leveraging artificial intelligence for drug discovery, reported a significantly wider loss for…
Praxis Precision Medicines faces major setback in ulixacaltamide trial but remains committed to Essential3 study
Praxis Precision Medicines (NASDAQ: PRAX), a clinical-stage biopharmaceutical company specializing in treatments for central nervous system disorders, encountered…
Regenerative medicine firm Organogenesis stock skyrockets 73% after surprise Q4 profit
Organogenesis Holdings Inc., a leading player in regenerative medicine, has reported a fourth-quarter profit that significantly exceeded market…
ALK’s ODACTRA gains FDA approval for pediatric house dust mite allergy treatment
The U.S. Food and Drug Administration (FDA) has expanded the approved use of ODACTRA house dust mite allergy…
Lilly’s Jaypirca moves closer to European approval for relapsed chronic lymphocytic leukemia
Eli Lilly and Company (Lilly) has moved one step closer to securing European approval for its targeted blood…